Oncternal Therapeutics Inc Financial Flexibility Index
Oncternal Therapeutics Inc financial flexibility index. Oncternal Therapeutics Inc (ONCT) has a Financial Flexibility Index of -1.08x as of September 2024. Free cash flow of $-6.95 Million (operating CF $-6.95 Million minus capex $0.00) represents -1% of total liabilities ($6.45 Million). See Oncternal Therapeutics Inc (ONCT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Oncternal Therapeutics Inc (2002–2023)
Financial flexibility index of Oncternal Therapeutics Inc from 2002 to 2023. Historical Financial Flexibility Index trend for Oncternal Therapeutics Inc across 22 annual periods. Check ONCT operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Oncternal Therapeutics Inc Financial Flexibility Index by Year (2002–2023)
Oncternal Therapeutics Inc financial flexibility index by year from 2002 to 2023. Year-by-year free cash flow to debt coverage for Oncternal Therapeutics Inc. For the full cash flow conversion analysis, see Oncternal Therapeutics Inc cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -4.82x | $-32.16 Million | $-32.16 Million | $6.68 Million | ▼ -0.8% |
| 2022 | -4.78x | $-36.70 Million | $-36.70 Million | $7.68 Million | ▲ +1.8% |
| 2021 | -4.87x | $-26.59 Million | $-26.59 Million | $5.46 Million | ▼ -62.9% |
| 2020 | -2.99x | $-17.50 Million | $-17.50 Million | $5.86 Million | ▼ -32.5% |
| 2019 | -2.25x | $-16.75 Million | $-16.75 Million | $7.43 Million | ▲ +70.2% |
| 2018 | -7.55x | $-39.35 Million | $-39.35 Million | $5.21 Million | ▼ -156.7% |
| 2017 | -2.94x | $-23.46 Million | $-23.46 Million | $7.97 Million | ▲ +34.4% |
| 2016 | -4.49x | $-20.69 Million | $-20.78 Million | $4.61 Million | ▼ -575.8% |
| 2015 | -0.66x | $-20.03 Million | $-20.04 Million | $30.17 Million | ▲ +24.2% |
| 2014 | -0.88x | $-28.75 Million | $-28.76 Million | $32.82 Million | ▲ +90.2% |
| 2013 | -8.93x | $-43.94 Million | $-43.97 Million | $4.92 Million | ▼ -143.3% |
| 2012 | -3.67x | $-36.97 Million | $-37.11 Million | $10.07 Million | ▲ +29.9% |
| 2011 | -5.24x | $-33.03 Million | $-33.09 Million | $6.31 Million | ▼ -115.4% |
| 2010 | -2.43x | $-30.43 Million | $-30.53 Million | $12.52 Million | ▼ -255.8% |
| 2009 | -0.68x | $-45.40 Million | $-46.00 Million | $66.47 Million | ▼ -259735.4% |
| 2008 | 0.00x | $-20.00K | $-2.92 Million | $76.09 Million | ▲ +99.9% |
| 2007 | -0.44x | $-35.90 Million | $-37.63 Million | $80.81 Million | ▼ -31.5% |
| 2006 | -0.34x | $-10.88 Million | $-11.46 Million | $32.21 Million | ▲ +90.8% |
| 2005 | -3.67x | $-33.88 Million | $-34.82 Million | $9.23 Million | ▼ -132.2% |
| 2004 | -1.58x | $-14.50 Million | $-15.67 Million | $9.17 Million | ▼ -1954.3% |
| 2003 | -0.08x | $-12.89 Million | $-13.00 Million | $167.54 Million | ▲ +50.9% |
| 2002 | -0.16x | $-10.24 Million | $-10.55 Million | $65.34 Million | — |